Advertisement
UK markets closed
  • FTSE 100

    8,317.59
    -21.64 (-0.26%)
     
  • FTSE 250

    20,770.93
    +139.63 (+0.68%)
     
  • AIM

    810.02
    +5.00 (+0.62%)
     
  • GBP/EUR

    1.1737
    +0.0000 (+0.00%)
     
  • GBP/USD

    1.2739
    +0.0041 (+0.32%)
     
  • Bitcoin GBP

    53,914.20
    +1,151.91 (+2.18%)
     
  • CMC Crypto 200

    1,444.06
    -24.04 (-1.64%)
     
  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     
  • DOW

    39,069.59
    +4.33 (+0.01%)
     
  • CRUDE OIL

    77.80
    +0.93 (+1.21%)
     
  • GOLD FUTURES

    2,335.20
    -2.00 (-0.09%)
     
  • NIKKEI 225

    38,646.11
    -457.11 (-1.17%)
     
  • HANG SENG

    18,608.94
    -259.77 (-1.38%)
     
  • DAX

    18,693.37
    +2.05 (+0.01%)
     
  • CAC 40

    8,094.97
    -7.36 (-0.09%)
     

Enovis Corporation (NYSE:ENOV) Q1 2024 Earnings Call Transcript

Enovis Corporation (NYSE:ENOV) Q1 2024 Earnings Call Transcript May 2, 2024

Enovis Corporation reports earnings inline with expectations. Reported EPS is $0.5 EPS, expectations were $0.5. Enovis Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good day and welcome to the Enovis First Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator instructions] Please note this event is being recorded. And now I would like to turn the conference over to Kyle Rose, vice president of investor relations. Please go ahead.

Kyle Rose: Thank you, Mayor Elise. Good morning, everyone, and thank you for joining us today on our first quarter 2024 results conference call. I'm Kyle Rose, Vice President of Investor Relations. Joining me on the call today are Matt Trerotola, Chair and Chief Executive Officer, and Ben Berry, Chief Financial Officer. Our earnings release was issued earlier this morning and is available in the Investor Relations section of our website, enovis.com. We will be using a slide presentation in today's call, which can also be found on our website. Both the audio and the slide presentation of this call will be archived on the website later today. During the call, we'll be making some forward looking statements about our beliefs and estimates regarding future events and results.

A patient recieving cold therapy treatment using the company's products.
A patient recieving cold therapy treatment using the company's products.

These forward looking statements are subject to risks and uncertainties, including those set forth in the safe harbor language in today's earnings release and in our filings with the SEC. Actual results might differ materially from any forward looking statements that we make. The forward looking statements speak only as of today, and we do not assume any obligation or intend to update them except as required by law. For further details regarding any non-GAAP financial measures referenced during the call today, the accompanying Reconciliation information relating to those measures can be found in our earnings press release and in the appendix of today's slide presentation. With that, let me turn it over to Matt, who will begin on slide three.

ADVERTISEMENT

Matt?

Matthew Trerotola: Thanks Kyle. Hello everyone, and thanks for joining us this morning. We had a strong first quarter, but before I begin to discuss the results, I want to welcome the Lima organization to Enovis and recognize the efforts of our strong global teams who work hard every day to execute our strategies and help our patients live more active and fulfilling lives. Please note that as we fully integrate into one company with a global focus, we're managing the organization on a combined global basis and we use pro forma growth for comparative purposes for year-over-year comparisons. Our prior year financials have been updated to include the acquisitions at Lima and NovaStep. Let's start on slide three and talk about some of the quarter's highlights.

See also

25 Best Self-Help Books for Women According to Reddit and

15 Biggest Aircraft Carriers in the World.

To continue reading the Q&A session, please click here.